HighlightLL Pharma - Crunchbase Company Profile & Funding

Q: Where is HighlightLL Pharma's headquarters?

HighlightLL Pharma is located in Hangzhou, Zhejiang, China.

Q: Who invested in HighlightLL Pharma?

HighlightLL Pharma has 8 investors including Huajin Capital And Hankang Capital.

Q: How much funding has HighlightLL Pharma raised to date?

HighlightLL Pharma has raised obfuscated.

Overview

HighlightLL Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About HighlightLL Pharma

CB Rank

74937

HighlightLL Pharma is a pharmaceutical company.

Private

Series C

Hangzhou, Zhejiang, China

11-50

highlightllpharma.com/

Medical

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Details

Legal Name

HighlightLL Pharmaceutical

Also Known As

HighlightLL Pharmaceuticals, Gaoguang Pharmaceutical, 高光制药

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

About the Company

HighlightLL Pharma is a pharmaceutical company.

Phone Number

+86 0571-8888-1586

Contact Email

info@highlightllpharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

TLL-018

A selective TYK2/JAK1 dual inhibitor drug candidate for treating autoimmune and inflammatory diseases, currently in phase II clinical trials in the US and Europe.

Research & Development

HighlightLL Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - HighlightLL Pharma	4	obfuscated obfuscation	—	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Huajin Capital	—	Series C - HighlightLL Pharma	—
Huajin Capital	—	Series C - HighlightLL Pharma	—
Huajin Capital	—	Series C - HighlightLL Pharma	—
Huajin Capital	—	Series C - HighlightLL Pharma	—
Huajin Capital	—	Series C - HighlightLL Pharma	—

Investments

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation
obfuscated obfuscation	Biohaven Pharmaceutical	Yes	Post-IPO Equity - Biohaven Pharmaceutical	obfuscated obfuscation